Regeneron Pharmaceuticals, Inc.
REGN
$589.48
-$8.68-1.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.47B | 8.35B | 9.01B | 9.80B | 9.81B |
| Total Receivables | 5.61B | 5.56B | 6.21B | 6.11B | 5.72B |
| Inventory | 3.21B | 3.19B | 3.09B | 3.02B | 2.87B |
| Prepaid Expenses | 554.50M | 466.10M | 348.40M | 412.00M | 674.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 19.80M | 2.80M | 800.00K | -- | 7.50M |
| Total Current Assets | 16.86B | 17.57B | 18.66B | 19.33B | 19.08B |
|
|
|||||
| Total Current Assets | 16.86B | 17.57B | 18.66B | 19.33B | 19.08B |
| Net Property, Plant & Equipment | 4.84B | 4.69B | 4.82B | 4.44B | 4.31B |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.35B | 1.17B | 1.15B | 1.12B | 1.10B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.70B | 4.45B | 4.07B | 3.90B | 3.68B |
| Total Assets | 38.22B | 37.55B | 37.76B | 37.44B | 36.09B |
|
|
|||||
| Total Accounts Payable | 723.90M | 705.50M | 789.50M | 497.30M | 561.70M |
| Total Accrued Expenses | 2.46B | 2.24B | 2.50B | 2.54B | 2.36B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 30.30M | -- | -- |
| Total Finance Division Other Current Liabilities | 481.90M | 619.30M | 627.70M | 627.20M | 586.00M |
| Total Other Current Liabilities | 481.90M | 619.30M | 627.70M | 627.20M | 586.00M |
| Total Current Liabilities | 3.67B | 3.57B | 3.94B | 3.66B | 3.51B |
|
|
|||||
| Total Current Liabilities | 3.67B | 3.57B | 3.94B | 3.66B | 3.51B |
| Long-Term Debt | 1.99B | 1.98B | 1.98B | 1.98B | 1.98B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 720.00M | 720.00M | 924.10M | 720.00M | 720.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.91B | 1.89B | 1.55B | 1.75B | 1.67B |
| Total Liabilities | 8.28B | 8.16B | 8.41B | 8.12B | 7.88B |
|
|
|||||
| Common Stock & APIC | 13.49B | 13.19B | 12.86B | 12.70B | 12.32B |
| Retained Earnings | 33.68B | 32.38B | 31.67B | 30.76B | 29.41B |
| Treasury Stock & Other | -17.23B | -16.19B | -15.18B | -14.13B | -13.53B |
| Total Common Equity | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.94B | 29.39B | 29.35B | 29.33B | 28.21B |
|
|
|||||